Downstaging hepatocellular carcinoma prior to liver transplantation
β Scribed by T. Clark Gamblin; David A. Geller
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 52 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.20528
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Salvage liver transplantation has been performed for recurrent hepatocellular carcinoma (HCC) or deterioration of liver function after primary liver resection. Because prior liver resection per se is an unfavorable condition for living donor liver transplantation (LDLT), we assessed the technical fe
We enjoyed the article by Yao et al. in the recent issue of HEPATOL-OGY 1 in which they report an excellent outcome of liver transplantation (LT) following preoperative down-staging of hepatocellular carcinoma (HCC). Yao et al. selected HCCs without vascular invasion by imaging studies and out of t
Background: Liver transplantation for unresectable hepatocellular carcinoma yields disappointing results. Most cases recur within 2 years, often in the transplanted liver. Methods: A combination of neoadjuvant doxorubicin and orthotopic liver transplantation was used in 20 patients with unresectable
This study was partially supported by grants UBACYT M055 (Universidad de Buenos Aires) and PICT 06-124 (Agencia Nacional de PromocioΒ΄n Cien-tΔ±Β΄fica y TecnoloΒ΄gica).